City Site - a new Clinical Research unit

February 04, 2008
A+ Science Clinical Services AB launches a Clinical Pharmaceutical Research unit in the heart of Stockholm. The doors open up today in one of the tall buildings located at Hötorget on Sveavägen 17. The research unit, A+ Science City Site, will be conducting clinical trials within many different therapeutic fields. The unit is well equipped and accessible for patient recruitment within a very short time. A+ Science specializes in clinical trials and through this specialization it promises a faster accomplishment and top quality trials. The clients are pharmaceutical companies, medical device companies and individual researchers.

The staff at A+ Science City Site consists of experienced Study Nurses. Dr. Anders Tamsen has the medical responsibility. Already from the start, A+ science City Site is conducting a diabetes phase II study in collaboration with Bengt Olov Tengmark, M.D. as the Principal Investigator.

”It feels natural to collaborate with A+ Science City Site, which has a long experience within clinical trials when they now establish a unit in the centre of Stockholm”, says Bengt Olov Tengmark, M.D.

A common problem for conducting clinical trials is to find the adequate number of persons expected to participate in trials. Having a central geographic site like Hötorget is an advantage since it facilitates the accessibility for those interested to participate.

”We have a good clinical network and well established channels in order to find patients, which in combination with the geographical accessibility makes it possible for us to have a sufficient trial participation” says Camilla Andersson, Head of Unit for A+ Science City Site, and the Managing Director of A+ Science Clinical Services AB.

A+ Science Clinical Services AB outsources Study Nurses for clinical pharmaceutical trials and other research projects. The company is part of the A+ Science Group which plans and conducts clinical trials on behalf of international pharmaceutical, biotechnical and medical device companies as well as for clinical research groups. A+ Science Group is owned by Vita Nova Ventures AB, a company which focuses exclusively in the life sciences area and is quoted on AktieTorget, Inc.

Stockholm, February 4th 2008
A+ Science Clinical Services AB

For further information contact:

Camilla Andersson, Managing Director, A+ Science Clinical Services AB
+46 706-03 41 75, camilla-(d_)-_andersson-(_sm3Remove)-_-(_a)-_a-pluscs-(d_)-_co

Return to news list